The present invention relates to a novel artemisinin or deoxoartemisinin-glycolipid hybrid derivatives and antiangiogenic use thereof. The artemisinin or deoxoartemisinin-glycolipid hybrid derivatives of the present invention exhibit two or more times stronger activity than the existing drugs and little or no cellular toxicity to address safety to human body.
本发明涉及一种新型
青蒿素或去氧
青蒿素-
糖脂杂化衍
生物及其抗血管生成作用。本发明的
青蒿素或去氧
青蒿素-
糖脂杂化衍
生物表现出比现有药物强两倍或更多的活性,并且几乎没有细胞毒性,以解决对人体安全性的问题。